APN Health

Executive Summary

APN Health, LLC is a next-generation medical device company based in Milwaukee, Wisconsin, specializing in innovative cardiac imaging. The company has developed Navik 3D, a proprietary, hardware-agnostic software algorithm that transforms standard X-ray systems into advanced 3D cardiac imaging platforms. By eliminating the need for expensive dedicated equipment, Navik 3D aims to make high-quality 3D imaging accessible and cost-effective for a broader range of healthcare facilities, potentially improving procedural outcomes in electrophysiology and structural heart interventions. Founded in 2015, APN Health targets the growing digital health and diagnostics market, addressing the critical need for accurate, real-time 3D visualization during minimally invasive cardiac procedures. The company's technology has the potential to reduce procedure times and enhance patient safety, positioning it as a disruptive player in the cardiac imaging space. APN Health's progress to date includes proprietary patented algorithms and a clear value proposition. However, as a private company with limited public information, its commercial traction and regulatory milestones remain uncertain. The company likely requires additional clinical validation, FDA clearances, and strategic partnerships to scale. Given the competitive landscape and the capital-intensive nature of medtech, APN Health must demonstrate clear clinical and economic benefits to gain adoption. With increasing focus on value-based care and minimally invasive techniques, Navik 3D is well-positioned if successfully commercialized. The next 12-24 months will be critical for achieving key regulatory and commercial milestones.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for Navik 3D60% success
• Q4 2026Strategic Partnership with Major Cardiac Device Manufacturer40% success
• Q2 2026Publication of Clinical Study Results Demonstrating Improved Outcomes70% success